Epstein–Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFκB pathway
- 1 December 2001
- journal article
- Published by Springer Nature in Genes & Immunity
- Vol. 2 (8) , 433-441
- https://doi.org/10.1038/sj.gene.6363803
Abstract
Genes and Immunity is a journal dedicated to functional genetics of the immune response. Emphasizing studies that demonstrate genetic, genomic or functional variation in the immune system, Genes and Immunity assists our understanding of how the basic control over the immune system varies between individuals both in health and disease.Keywords
This publication has 48 references indexed in Scilit:
- Characterization of Intercellular Adhesion Molecule-1 Regulation by Epstein-Barr Virus-encoded Latent Membrane Protein-1 Identifies Pathways That Cooperate with Nuclear Factor κB to Activate TranscriptionJournal of Biological Chemistry, 2001
- The AT-rich region between −54 to −66 is important for the promoter activity of interleukin-10 in Epstein–Barr virus positive Burkitt’s lymphoma cellsGenes & Immunity, 1999
- c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector functionInternational Immunology, 1999
- Epstein–Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regionsOncogene, 1998
- Defective IκBα in Hodgkin cell lines with constitutively active NF-κBOncogene, 1998
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997
- Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factorsOncogene, 1997
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Epidemiology of EBV and Hodgkin's lymphomaAnnals of Oncology, 1996
- IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: Promotion of IL6 receptor expression by EBVHematological Oncology, 1995